戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 s was defined as the eyelid hanging over the eyelashes.
2  patients) to 40.9% (56 of 137 patients) for eyelashes.
3 ongenital diseases can lead to short or long eyelashes.
4 for the presence of Demodex mites on sampled eyelashes.
5                     However, there were less eyelash (0.0% vs 3.0%, P = .003) and eyelid/orbital side
6 nificant increase in Demodex colonization of eyelashes after cataract surgery and postoperative topic
7 ption of severity as well as the presence of eyelash and eyebrow hair loss are also impactful and sho
8 ut 20% to 30% of patients exhibited moderate eyelash and/or eyelid changes.
9 g the bottle by contact with ocular surface, eyelashes, and skin.
10 air loss, facial hair involvement (eyebrows, eyelashes, and/or beard), nail involvement, impaired qua
11 imb lymphedema and an aberrant second row of eyelashes arising from the meibomian glands.
12 d rodent pelage follicles in vivo, mirroring eyelash behavior, and scalp follicles contain bimatopros
13 ing scalp and body hair, sparse eyebrows and eyelashes, decreased sweating, hypodontia, and nail anom
14 th variable age at onset, and double rows of eyelashes (distichiasis).
15                                              Eyelashes evolved to protect eyes.
16       Therefore, we investigated whether non-eyelash follicles could respond to bimatoprost, a prosta
17 tes, including conjunctival goblet cells and eyelash follicles, are ectopically permitted within more
18  the results showed that the most attractive eyelashes for Black women were skewed toward a greater e
19    The diagnosis was based on epilation of 4 eyelashes from each upper eyelid.
20  This indicates the importance of preventing eyelashes from touching the cornea, particularly in indi
21 t another serendipitous discovery, increased eyelash growth side-effects of prostamide F(2alpha)-rela
22 a therapeutic target to selectively regulate eyelash growth.
23 ented with familial trichomegaly, or extreme eyelash growth.
24 n-reported outcome for eyebrow hair loss and eyelash hair loss scores of 0 or 1 (full coverage or min
25  subsequent 24 weeks for scalp, eyebrow, and eyelash hair loss.
26  meaningful outcomes for scalp, eyebrow, and eyelash hair regrowth in patients with severe alopecia a
27                                              Eyelash hairs and follicles are highly specialized and r
28       Mechanisms that regulate the growth of eyelashes have remained obscure.
29 , (2) palpebral (e.g., eyelash trichomegaly, eyelash hypertrichosis, eyelid erythema, eyelid edema, e
30 amide F(2alpha) analog recently licensed for eyelash hypotrichosis.
31  arms and legs in 52 (42%), and eyebrows and eyelashes in 47 each (38%).
32 s from successful repigmentation of skin and eyelashes in affected individuals, regardless of SSV or
33 sex (females more impacted), and eyebrow and eyelash involvement were predictors of diminished QOL, c
34                              A second row of eyelashes is a feature of human lymphedema-distichiasis
35 lack, and White men and women preference for eyelash length followed an inverted-U function across al
36                                   An optimum eyelash length functions to protect eyes from external h
37 a recent investigation on the preference for eyelash length in humans from an evolutionary adaptive p
38 y tested whether the inverted-U function for eyelash length preference recently reported for White fa
39 s, supporting a general preference for human eyelash length that is approximately one-third the width
40 eflect a change in perceptual sensitivity to eyelash length with skin colour or changes in preference
41 for Black women were skewed toward a greater eyelash-length to eye-width ratio when compared to the o
42 r ethnic background modulates preference for eyelash lengths.
43 , Asian, Black, and White faces with varying eyelash lengths.
44  discomfort, cutaneous erythema, blistering, eyelash loss, and floaters; these were uniformly self-li
45 ighly arched bushy eyebrows, synophrys, long eyelashes, low-set ears, microdontism of primary teeth,
46 mptom-based PROMs (PRO measures for eyebrow, eyelash, nail appearance, and eye irritation, and Scalp
47 determine the prevalence of Demodex mites in eyelashes of Austrian patients with ocular discomfort an
48 omatous trichiasis (TT; one or more inturned eyelashes) or inflammatory trachoma without trichiasis a
49  contact between the bottle tip and the eye, eyelashes, or skin compared with those without (glaucoma
50 touching the ocular surface (P = 0.046), the eyelashes (P = 0.020), or the skin (P = 0.025) with the
51                                          The eyelashes ranged in length from no eyelashes to half the
52 oncentration of sevoflurane upon loss of the eyelash reflex to prevent epileptiform activity has not
53 ficacy and rare AEs; however, the absence of eyelash-related changes and prostaglandin associated per
54 went cataract extraction surgery had several eyelashes removed preoperatively that were examined inde
55 of bottle tip contact with the eye, skin, or eyelashes, suggesting an increased risk of potential eye
56       The eyelashes ranged in length from no eyelashes to half the width of an eye.
57 lid trachomatous trichiasis with one or more eyelashes touching the eye or evidence of epilation, in
58 f the conjunctiva, and potentially in-turned eyelashes (trachomatous trichiasis) in later life.
59  scarring, and potentially blinding inturned eyelashes (trichiasis or entropion) in later life.
60                                              Eyelash trichomegaly and hypertrichosis (n = 22, 76%), h
61 omia, and buphthalmos), (2) palpebral (e.g., eyelash trichomegaly, eyelash hypertrichosis, eyelid ery
62 ve and first-month postoperative visits, two eyelashes were collected from the upper and lower eyelid
63 eening and on days 15, 22, and 43, 4 or more eyelashes were epilated from each eye, and the number of
64 al gestalt (interrupted wavy eyebrows, dense eyelashes, wide nose, wide mouth, and a prominent chin)